USANA Health Price To Book vs. Current Valuation

USNA Stock  USD 38.53  0.63  1.61%   
Considering the key profitability indicators obtained from USANA Health's historical financial statements, USANA Health Sciences is yielding more profit at this time then in previous quarter. It has a moderate probability of reporting better profitability numbers in January. Profitability indicators assess USANA Health's ability to earn profits and add value for shareholders. The current year's Price To Sales Ratio is expected to grow to 1.14. The current year's Days Sales Outstanding is expected to grow to 3.17. At present, USANA Health's Total Other Income Expense Net is projected to increase significantly based on the last few years of reporting. The current year's Net Income From Continuing Ops is expected to grow to about 95.4 M, whereas Accumulated Other Comprehensive Income is projected to grow to (13 M).
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.640.73
Fairly Down
Slightly volatile
Net Profit Margin0.06740.0625
Significantly Up
Pretty Stable
Operating Profit Margin0.10.097
Sufficiently Up
Slightly volatile
Pretax Profit Margin0.10.0979
Fairly Up
Pretty Stable
Return On Assets0.250.13
Way Up
Pretty Stable
Return On Equity0.170.18
Notably Down
Slightly volatile
For USANA Health profitability analysis, we use financial ratios and fundamental drivers that measure the ability of USANA Health to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well USANA Health Sciences utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between USANA Health's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of USANA Health Sciences over time as well as its relative position and ranking within its peers.
  

USANA Health's Revenue Breakdown by Earning Segment

Check out World Market Map.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of USANA Health. If investors know USANA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about USANA Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.06)
Earnings Share
2.83
Revenue Per Share
45.085
Quarterly Revenue Growth
(0.06)
Return On Assets
0.0809
The market value of USANA Health Sciences is measured differently than its book value, which is the value of USANA that is recorded on the company's balance sheet. Investors also form their own opinion of USANA Health's value that differs from its market value or its book value, called intrinsic value, which is USANA Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because USANA Health's market value can be influenced by many factors that don't directly affect USANA Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between USANA Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if USANA Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, USANA Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

USANA Health Sciences Current Valuation vs. Price To Book Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining USANA Health's current stock value. Our valuation model uses many indicators to compare USANA Health value to that of its competitors to determine the firm's financial worth.
USANA Health Sciences is rated below average in price to book category among its peers. It is rated below average in current valuation category among its peers reporting about  295,694,911  of Current Valuation per Price To Book. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the USANA Health's earnings, one of the primary drivers of an investment's value.

USANA Health's Earnings Breakdown by Geography

USANA Current Valuation vs. Price To Book

Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

USANA Health

P/B

 = 

MV Per Share

BV Per Share

 = 
1.38 X
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

USANA Health

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
407.35 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

USANA Current Valuation vs Competition

USANA Health Sciences is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Consumer Staples industry is at this time estimated at about 46.7 Billion. USANA Health maintains roughly 407.35 Million in current valuation contributing less than 1% to stocks in Consumer Staples industry.

USANA Health Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in USANA Health, profitability is also one of the essential criteria for including it into their portfolios because, without profit, USANA Health will eventually generate negative long term returns. The profitability progress is the general direction of USANA Health's change in net profit over the period of time. It can combine multiple indicators of USANA Health, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income-13.7 M-13 M
Operating Income93.1 M81.3 M
Net Income63.8 M55.4 M
Income Tax Expense38.7 M28.2 M
Income Before Tax102.5 M84.6 M
Total Other Income Expense Net9.4 M9.9 M
Net Income Applicable To Common Shares79.8 M65.4 M
Net Income From Continuing Ops59.8 M95.4 M
Non Operating Income Net Other583 K553.9 K
Interest Income8.2 M8.6 M
Net Interest IncomeM8.4 M
Change To Netincome7.2 M12.6 M
Net Income Per Share 3.24  3.40 
Income Quality 1.72  1.64 
Net Income Per E B T 0.57  0.52 

USANA Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on USANA Health. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of USANA Health position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the USANA Health's important profitability drivers and their relationship over time.

Use USANA Health in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if USANA Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in USANA Health will appreciate offsetting losses from the drop in the long position's value.

USANA Health Pair Trading

USANA Health Sciences Pair Trading Analysis

The ability to find closely correlated positions to USANA Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace USANA Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back USANA Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling USANA Health Sciences to buy it.
The correlation of USANA Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as USANA Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if USANA Health Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for USANA Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your USANA Health position

In addition to having USANA Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Casinos Thematic Idea Now

Casinos
Casinos Theme
Companies that are related to providing casino-type services across multiple geographical areas. The Casinos theme has 51 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Casinos Theme or any other thematic opportunities.
View All  Next Launch
When determining whether USANA Health Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of USANA Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Usana Health Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Usana Health Sciences Stock:
Check out World Market Map.
You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
To fully project USANA Health's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of USANA Health Sciences at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include USANA Health's income statement, its balance sheet, and the statement of cash flows.
Potential USANA Health investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although USANA Health investors may work on each financial statement separately, they are all related. The changes in USANA Health's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on USANA Health's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.